Ormazabal, M.E.; Pavan, E.; Vaena, E.; Ferino, D.; Biasizzo, J.; Mucci, J.M.; Serra, F.; Cifù, A.; Scarpa, M.; Rozenfeld, P.A.;
et al. Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology. Int. J. Mol. Sci. 2023, 24, 11204.
https://doi.org/10.3390/ijms241311204
AMA Style
Ormazabal ME, Pavan E, Vaena E, Ferino D, Biasizzo J, Mucci JM, Serra F, Cifù A, Scarpa M, Rozenfeld PA,
et al. Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology. International Journal of Molecular Sciences. 2023; 24(13):11204.
https://doi.org/10.3390/ijms241311204
Chicago/Turabian Style
Ormazabal, Maximiliano Emanuel, Eleonora Pavan, Emilio Vaena, Dania Ferino, Jessica Biasizzo, Juan Marcos Mucci, Fabrizio Serra, Adriana Cifù, Maurizio Scarpa, Paula Adriana Rozenfeld,
and et al. 2023. "Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology" International Journal of Molecular Sciences 24, no. 13: 11204.
https://doi.org/10.3390/ijms241311204
APA Style
Ormazabal, M. E., Pavan, E., Vaena, E., Ferino, D., Biasizzo, J., Mucci, J. M., Serra, F., Cifù, A., Scarpa, M., Rozenfeld, P. A., & Dardis, A. E.
(2023). Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology. International Journal of Molecular Sciences, 24(13), 11204.
https://doi.org/10.3390/ijms241311204
